KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
International health agencies, including the World Health Organization, have stepped in to support local medical teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo has launched an Ebola vaccination initiative as health workers intensify ring-vaccination strategies around identified infection clusters to block viral transmission pathways.
Health Department Focuses Ervebo Vaccines on Kisangani Medical Personnel
Operational hurdles hinder logistics due to regional infrastructure challenges, persistent security issues, and high mobility across border areas. Cold-chain supply networks have been established in Kisangani to ensure vaccines are stored at ultra-low temperatures before reaching remote health zones. DR Congo launches Ebola vaccination campaign, supported by civil defense and community health workers conducting outreach to enhance disease surveillance and reporting.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working closely with local response teams to monitor adverse effects and assess immune responses in vaccinated groups. Officials highlighted that early clinical detection, along with isolation procedures and supportive treatment, remains vital for improving patient outcomes. Additional vaccine shipments are planned as regional distribution extends to secondary health districts.
Authorities Strengthen Infection Control Practices at Ebola Treatment Facilities
National response teams are intensifying contact tracing across urban and rural areas in the eastern region. Local health centers are receiving protective gear, diagnostic reagents, and treatment supplies to improve readiness. The government has affirmed that public health measures will stay in place until transmission metrics show consistent declines in all affected provinces.
The government has called on communities to fully cooperate with vaccination teams and adhere to established sanitary protocols. Experts believe that increasing immunization coverage among high-risk populations will help stabilize infection rates in the upcoming weeks. Surveillance networks will continue heightened monitoring at transportation hubs and border crossings to prevent further spread.